News

New Study Finds Higher Prevalence of Age-Related Macular Degeneration (AMD) Cases than Previously Determined and a High Degree of County Variation

A new study “The Prevalence of Age-Related Macular Degeneration in the United States In 2019” published in JAMA Ophthalmology, found that in 2019, there were an estimated 19.83 million Americans were living with some form of age-related macular degeneration (AMD) in 2019. This is an increase of approximately more than 2.75 times previous estimates (which used a more [Read More]

Susvimo implant for Wet AMD Voluntarily Recalled

Susvimo, previously called Port Delivery System with ranibizumab (Lucentis), was FDA-approved on October 21, 2021, for intravitreal use via ocular implant for the treatment of people with wet (neovascular) age-related macular degeneration (AMD). Now, one year later, Genentech has announced that it is voluntarily recalling the implant and the insertion tool in the U.S. As [Read More]

Samsara Vision Announces Clinical Trial for New Investigational Implantable Miniature Telescope

CONCERTO clinical trial is seeking participants to evaluate the new investigational SING IMT Long-time members of our AMD community may remember FDA approval in 2010 of a device from Samsara Vision (formerly VisionCare, Inc.) called the Implantable Miniature Telescope (IMT). This device is a tiny telescope which provides precision images, magnification of up to 3 times, [Read More]

1 2 3 111